Management of Acute Coronary Syndromes / Edition 1

Paperback (Print)
Buy New
Buy New from BN.com
$173.34
Used and New from Other Sellers
Used and New from Other Sellers
from $5.50
Usually ships in 1-2 business days
(Save 97%)
Other sellers (Paperback)
  • All (15) from $5.50   
  • New (11) from $24.95   
  • Used (4) from $5.50   

Overview

In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.

The book contains predominantly black-and-white illustrations, with some color illustrations.

This book defines and illustrates the new paradigm of acute coronary syndromes, defining acute myocardial infarction and unstable angina as part of a spectrum of myocardial ischemia. It presents the current state-of-the-art management of the disease including aggressive thrombolytic, andithrombotic, and interventional approaches.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Leslie Cho, MD (Loyola University Stritch School of Medicine)
Description: This book provides a full review of acute coronary syndromes (ACS) from pathophysiology to management.
Purpose: The purpose is to provide a comprehensive review of ACS using the new paradigm of ST elevation MI vs. non-ST elevation MI. The book provides a good review of the pathophysiology, diagnosis, treatment, and prevention of this wide spectrum of syndromes. Since this is an ever changing field, such a book could potentially provide a comprehensive review of pertinent literature. This book is adequate in providing a comprehensive review of literature, but in many of the chapters it regurgitates trial information without providing any further insight.
Audience: The book is mainly for residents, cardiology fellows, and cardiologists, as well as emergency physicians and residents. Some authors are recognized authorities in the field while others appear to be fellows.
Features: The book is a good comprehensive review of ACS. However, unlike the stated goal it is not up to the minute and, unfortunately, no book can be since this field is changing at a rapid rate. The major shortcoming of the book is that in some chapters, there is a mere regurgitation of trial data without a good synthesis of the information. There are other ACS books out there (Topol's Acute Coronary Syndromes, 2nd edition (Marcel Dekker, 2001), etc.) and for the most part all these books are similar.
Assessment: This is a useful and good book, but it is not as good as it could have been because of the regurgitation of trial data without synthesis of the findings. A second edition is warranted because the field is changing rapidly.
Keith McLean
This extremely well written and concise book covers unstable angina, ST segment elevation infarction, and ST segment depression infarction. It focuses on the pathophysiology, including cytokines and molecular biology of these syndromes. It gives evidence-based rationale for therapy with medications, thrombolytics, and angioplasty and also focuses on important adjunctive therapies, specifically with regard to antiplatelet agents. The purpose is to understand the pathophysiology of acute coronary syndromes from the microscopic to the macroscopic level and to apply this knowledge in treating patients with the wide spectrum of the disease process. It clearly separates ST segment elevation infarction from SI segment depression infarction and thoroughly explores the pathophysiologic differences, which are essential for rational treatment strategies. This book is written primarily for cardiologists and general internists, but is also an excellent source of information for medical students, internal medicine residents, and cardiology fellows. It stands by itself with extensive references from well known clinical studies that have formed the basis for clinical practice. This is an excellent and concise review of the spectrum of unstable angina, ST segment elevation infarction, and ST segment depression infarction. It focuses on the pathophysiology of the process with special emphasis on the role of inflammation, cytokines, and molecular biology. It also explains the biology of the process and resultant treatment implications. It spends a good deal of time on explaining the serum markers for myocardial ischemia as well as their pathophysiologic differences between ST elevation and STdepression infarction and the rationale for specific treatment strategies. Data on primary angioplasty and the thrombolytic trials are reviewed in detail. The importance of risk stratification is not overlooked nor is the importance of adjunctive therapy for myocardial inflection with beta blockers and angiotensin converting enzyme inhibitors. The numerous tables and charts are well designed and emphasize important topics covered in the text. There is also a specific chapter on novel agents in the treatment of MI and a review of the essential role of the platelet in the process as well as some of the newer antiplatelet agents. Specific topics such as myocardial infarction in younger patients with major emphasis on other factors such as homocysteine and Lp(a) are also covered. This book is an excellent summary of acute coronary syndromes. It is well thought out and easy to read, which allows the reader to assimilate a lot of information in a short period of time. Its clear writing and effective use of tables and graphics solidifies understanding this essential topic in cardiology. Compared with a similar book, Acute Coronary Syndromes, edited by Eric J. Topol (Marcel Dekker, 1998), this book seems to present the data in a more concise and reader-friendly fashion.
Booknews
Twenty-six articles draw on recent results of clinical trials to explain guidelines for patients with ST- and non-ST- elevation myocardial ischemia (MI), as well as to explore the pathophysiology and diagnosis of acute coronary syndrome (ACS). Subjects include information on thrombolytic therapy, risk stratification, antiplatelet and antithrombotic agents, a comparison of invasive versus conservative strategies, and primary angioplasty. A final section deals with special issues such as ACS and women, MI in younger patients, cardiogenic shock, cholesterol lowering, cost-effectiveness analysis in treatment, and secondary prevention of MI. Annotation c. by Book News, Inc., Portland, Or.

5 Stars! from Doody
Read More Show Less

Product Details

  • ISBN-13: 9781588293091
  • Publisher: Springer-Verlag New York, LLC
  • Publication date: 11/4/2002
  • Series: Contemporary Cardiology Series
  • Edition description: Softcover reprint of the original 1st ed. 2003
  • Edition number: 1
  • Pages: 783
  • Product dimensions: 7.01 (w) x 10.00 (h) x 1.59 (d)

Table of Contents

Part I. Pathophysiology

The Spectrum of Myocardial Ischemia: The Paradigm of Acute Coronary Syndromes
Christopher P. Cannon and Eugene Braunwald

Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes
Richard C. Becker and Annemarie Armani

Triggers of Acute Coronary Syndromes
Peter M. Sapin and James E. Muller

Insights into the Pathophysiology of Acute Ischemia Syndromes Using the TIMI Flow Grade, TIMI Frame Count, and TIMI Myocardial Perfusion Grade
C. Michael Gibson, Sabina A. Murphy, and Jeffrey J. Popma

Part II. Diagnosis

Emergency Department Presentations of Acute Cardiac Ischemia
J. Hector Pope and Harry P. Selker

Early Identification and Treatment of Patients with Acute Coronary Syndromes
Mary M. Hand and Costas T. Lambrew

Serum Markers for Diagnosis and Risk Stratification in Acute Coronary Syndromes
L. Kristin Newby, W. Brian Gibler, Robert H. Christenson, and E. Magnus Ohman

Technologies to Diagnose Acute Ischemia
Robert J. Zalenski, Joseph Lau, and Harry P. Selker

Part III. ST-Segment Elevation Myocardial Infarction

Thrombolytic Therapy
Jeffrey L. Anderson and James S. Zebrack

Primary Angioplasty
Sorin J. Brener and Eric J. Topol

Expanding the Access to Percutaneous Coronary Intervention for Patients Admitted to Community Hospitals
Thomas P. Wharton, Jr. and Nancy Sinclair McNamara

Antiplatelet and Anticoagulant Therapy
Marc S. Sabatine and Ik-Kyung Jang

b-Adrenergic Blockers, Calcium Channel Blockers, and Nitrates
Yerem Yeghiazarians and Peter H. Stone

Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction
Rodolfo Carrillo-Jimenez, Charles H. Hennekens, and Gervasio A. Lamas

Risk Stratification: Exercise Testing, Imaging, and Cardiac Catheterization
Sanjeev Puri, Hani A. Razek, and Bernard R. Chaitman

Part IV. Non-ST-Segment Elevation Myocardial Infarction

Anticoagulant Therapies, Marc Cohen. Antiplatelet Therapy
Ian Conde-Pozzi and Neal S. Kleiman

Thrombolytics and Invasive vs Conservative Strategies in Unstable Angina
Ali Moustapha and H. Vernon Anderson

Current Device Strategies in the Management of Acute Coronary Syndromes
Kanwar P. Singh and C. Michael Gibson

Part V. Special Aspects of Acute Coronary Syndromes

Women and Acute Coronary Syndromes
Jane A. Leopold and Alice K. Jacobs

The Modern Strategy for Cardiogenic Shock
Gary E. Lane and David R. Holmes, Jr.

Myocardial Infarction in the Younger Patient
James C. Fang and Jorge Plutzky

Cholesterol Lowering
Terje R. Pedersen and Serena Tonstad

'Secondary Prevention' of Myocardial Infarction
Jorge Plutzky and Roger S. Blumenthal

Cost and Cost-Effectiveness in Acute Coronary Syndromes
William S. Weintraub

Smoking Cessation
Beth C. Bock and Bruce Becker

Critical Pathways for Acute Coronary Syndromes
Christopher P. Cannon and Patrick T. O'Gara

Index

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)